Renin‐Angiotensin System Inhibitors in Patients With COVID‐19: A Meta‐Analysis of Randomized Controlled Trials Led by the International Society of Hypertension
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Renin‐Angiotensin System Inhibitors in Patients With COVID‐19: A Meta‐Analysis of Randomized Controlled Trials Led by the International Society of Hypertension
Authors
Keywords
-
Journal
Journal of the American Heart Association
Volume 11, Issue 17, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2022-08-24
DOI
10.1161/jaha.122.026143
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Randomized Controlled Trial of Renin-Angiotensin-Aldosterone System Inhibitor Management in Patients Admitted in Hospital with COVID-19
- (2022) Abhinav Sharma et al. AMERICAN HEART JOURNAL
- A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells
- (2022) Elena Garreta et al. Cell Metabolism
- Efficacy of Losartan in Hospitalized Patients With COVID-19–Induced Lung Injury
- (2022) Michael A. Puskarich et al. JAMA Network Open
- Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19
- (2021) Renato D. Lopes et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial
- (2021) Jordana B Cohen et al. Lancet Respiratory Medicine
- Comparison of losartan and amlodipine effects on the outcomes of patient with COVID‐19 and primary hypertension: A randomised clinical trial
- (2021) Masoud Nouri‐Vaskeh et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Renin–angiotensin-system inhibitors and all-cause mortality in patients with coronavirus disease 2019
- (2021) Chirag Bavishi et al. JOURNAL OF HYPERTENSION
- Prospective meta-analysis protocol on randomised trials of renin–angiotensin system inhibitors in patients with COVID-19: an initiative of the International Society of Hypertension
- (2021) Sonali Rukshana Gnanenthiran et al. BMJ Open
- Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
- (2021) Kazem Rahimi et al. LANCET
- Angiotensin Receptor Blockers for COVID-19: Pathophysiological and Pharmacological Considerations About Ongoing and Future Prospective Clinical Trials
- (2021) Rodolfo Pedro Rothlin et al. Frontiers in Pharmacology
- Randomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan to Hospitalized COVID-19 Patients with Mild Hypoxemia
- (2021) Matthew Geriak et al. Infectious Diseases and Therapy
- Evidence For and Against Direct Kidney Infection by SARS-CoV-2 in Patients with COVID-19
- (2021) Luise Hassler et al. Clinical Journal of the American Society of Nephrology
- Renin–angiotensin system inhibitor use and the risk of mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials
- (2021) Chia Siang Kow et al. HYPERTENSION RESEARCH
- A multi-center retrospective cohort study defines the spectrum of kidney pathology in Coronavirus 2019 Disease (COVID-19)
- (2021) Rebecca M. May et al. KIDNEY INTERNATIONAL
- Pathophysiology of COVID-19-associated acute kidney injury
- (2021) Matthieu Legrand et al. Nature Reviews Nephrology
- Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial
- (2021) Axel Bauer et al. Lancet Respiratory Medicine
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Association of renin-angiotensin-aldosterone system inhibitors with COVID-19-related outcomes in Korea: a nationwide population-based cohort study
- (2020) Sun-Young Jung et al. CLINICAL INFECTIOUS DISEASES
- Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis
- (2020) Xiu-wu Pan et al. INTENSIVE CARE MEDICINE
- Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia
- (2020) Guangchang Pei et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Collapsing glomerulopathy in a COVID-19 patient
- (2020) Sébastien Kissling et al. KIDNEY INTERNATIONAL
- Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study
- (2020) Francisco J de Abajo et al. LANCET
- Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
- (2020) Giuseppe Mancia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
- (2020) Harmony R. Reynolds et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues
- (2020) Meng-Yuan Li et al. Infectious Diseases of Poverty
- Management of acute kidney injury in patients with COVID-19
- (2020) Claudio Ronco et al. Lancet Respiratory Medicine
- Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China
- (2020) Juyi Li et al. JAMA Cardiology
- Renin-Angiotensin System Blockers and the COVID-19 Pandemic
- (2020) A.H. Jan Danser et al. HYPERTENSION
- COVID-19–Associated Kidney Injury: A Case Series of Kidney Biopsy Findings
- (2020) Purva Sharma et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19
- (2020) Jan Wysocki et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Collapsing Glomerulopathy in a Patient With COVID-19
- (2020) Christopher P. Larsen et al. Kidney International Reports
- Multicenter Clinicopathologic Correlation of Kidney Biopsies Performed in COVID-19 Patients Presenting With Acute Kidney Injury or Proteinuria
- (2020) Shreeram Akilesh et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- SARS-CoV-2 renal tropism associates with acute kidney injury
- (2020) Fabian Braun et al. LANCET
- COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup
- (2020) Mitra K. Nadim et al. Nature Reviews Nephrology
- RoB 2: a revised tool for assessing risk of bias in randomised trials
- (2019) Jonathan A C Sterne et al. BMJ-British Medical Journal
- Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT
- (2018) Rakesh Malhotra et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Effect of Intensive Blood Pressure Lowering on Kidney Tubule Injury: Findings From the ACCORD Trial Study Participants
- (2018) Girish N. Nadkarni et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With Outcomes After Acute Kidney Injury
- (2018) Sandeep Brar et al. JAMA Internal Medicine
- Risk of acute myocardial infarction after discontinuation of antihypertensive agents: a case–control study
- (2017) F F Alharbi et al. JOURNAL OF HUMAN HYPERTENSION
- Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes
- (2016) Yoichiro Hirakawa et al. JOURNAL OF HYPERTENSION
- Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
- (2016) Dena Ettehad et al. LANCET
- Ranking treatments in frequentist network meta-analysis works without resampling methods
- (2015) Gerta Rücker et al. BMC Medical Research Methodology
- Angiotensin-(1–9) reverses experimental hypertension and cardiovascular damage by inhibition of the angiotensin converting enzyme/Ang II axis
- (2014) Maria Paz Ocaranza et al. JOURNAL OF HYPERTENSION
- Trends in Antihypertensive Medication Use and Blood Pressure Control Among United States Adults With Hypertension
- (2012) Qiuping Gu et al. CIRCULATION
- Network meta-analysis, electrical networks and graph theory
- (2012) Gerta Rücker Research Synthesis Methods
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started